155 related articles for article (PubMed ID: 28481142)
1. Daptomycin: new insights into an antibiotic of last resort.
Pader V; Edwards AM
Future Microbiol; 2017 May; 12():461-464. PubMed ID: 28481142
[No Abstract] [Full Text] [Related]
2. Antimicrobial susceptibility of daptomycin and comparator agents tested against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: trend analysis of a 6-year period in US medical centers (2005-2010).
Sader HS; Moet GJ; Farrell DJ; Jones RN
Diagn Microbiol Infect Dis; 2011 Jul; 70(3):412-6. PubMed ID: 21546202
[TBL] [Abstract][Full Text] [Related]
3. In vitro susceptibility of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecium to daptomycin and other antibiotics.
Samra Z; Ofir O; Shmuely H
Eur J Clin Microbiol Infect Dis; 2007 May; 26(5):363-5. PubMed ID: 17410387
[No Abstract] [Full Text] [Related]
4. In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in Gram-positives.
Cafini F; Aguilar L; González N; Giménez MJ; Torrico M; Alou L; Sevillano D; Vallejo P; Prieto J
J Antimicrob Chemother; 2007 Jun; 59(6):1185-9. PubMed ID: 17412725
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of in vitro interaction of daptomycin with gentamicin or beta-lactam antibiotics against Staphylococcus aureus and Enterococci by FIC index and timed-kill curves.
Snydman DR; McDermott LA; Jacobus NV
J Chemother; 2005 Dec; 17(6):614-21. PubMed ID: 16433191
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of tedizolid against Staphylococcus aureus and enterococci with reduced susceptibility to vancomycin, daptomycin or linezolid.
Barber KE; Smith JR; Raut A; Rybak MJ
J Antimicrob Chemother; 2016 Jan; 71(1):152-5. PubMed ID: 26476277
[TBL] [Abstract][Full Text] [Related]
7. Ampicillin enhances daptomycin- and cationic host defense peptide-mediated killing of ampicillin- and vancomycin-resistant Enterococcus faecium.
Sakoulas G; Bayer AS; Pogliano J; Tsuji BT; Yang SJ; Mishra NN; Nizet V; Yeaman MR; Moise PA
Antimicrob Agents Chemother; 2012 Feb; 56(2):838-44. PubMed ID: 22123698
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of daptomycin against isolates of Staphylococcus aureus and enterococci: first results from Turkey.
Arslan H; Azap OK; Ergin F; Karaman SO; Oruç E
Int J Antimicrob Agents; 2004 Jun; 23(6):642-3. PubMed ID: 15194140
[No Abstract] [Full Text] [Related]
9. Oritavancin Combinations with β-Lactams against Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci.
Smith JR; Yim J; Raut A; Rybak MJ
Antimicrob Agents Chemother; 2016 Apr; 60(4):2352-8. PubMed ID: 26833159
[TBL] [Abstract][Full Text] [Related]
10. Failure of daptomycin β-Lactam combination therapy to prevent resistance emergence in Enterococcus faecium.
Menon V; Davis R; Shackel N; Espedido BA; Beukers AG; Jensen SO; van Hal SJ
Diagn Microbiol Infect Dis; 2018 Feb; 90(2):120-122. PubMed ID: 29195768
[TBL] [Abstract][Full Text] [Related]
11. Tedizolid as Step-Down Therapy following Daptomycin versus Continuation of Daptomycin against Enterococci and Methicillin- and Vancomycin-Resistant Staphylococcus aureus in a Rat Endocarditis Model.
Singh KV; Arias CA; Murray BE
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32122892
[TBL] [Abstract][Full Text] [Related]
12. β-Lactams increase the antibacterial activity of daptomycin against clinical methicillin-resistant Staphylococcus aureus strains and prevent selection of daptomycin-resistant derivatives.
Mehta S; Singh C; Plata KB; Chanda PK; Paul A; Riosa S; Rosato RR; Rosato AE
Antimicrob Agents Chemother; 2012 Dec; 56(12):6192-200. PubMed ID: 22985884
[TBL] [Abstract][Full Text] [Related]
13. In vitro activities of Daptomycin, Linezolid, and Quinupristin-Dalfopristin against a challenge panel of Staphylococci and Enterococci, including vancomycin-intermediate staphylococcus aureus and vancomycin-resistant Enterococcus faecium.
Jevitt LA; Smith AJ; Williams PP; Raney PM; McGowan JE; Tenover FC
Microb Drug Resist; 2003; 9(4):389-93. PubMed ID: 15000746
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of daptomycin against Staphylococcus aureus and vancomycin-resistant Enterococcus faecium isolates associated with skin and soft tissue infections: first results from India.
Dhawan B; Gadepalli R; Kapil A
Diagn Microbiol Infect Dis; 2009 Oct; 65(2):196-8. PubMed ID: 19748433
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of daptomycin alone and in combination with various antimicrobials against Gram-positive cocci.
Cilli F; Aydemir S; Tunger A
J Chemother; 2006 Feb; 18(1):27-32. PubMed ID: 16572890
[TBL] [Abstract][Full Text] [Related]
16. Daptomycin against multiple drug-resistant staphylococcus and enterococcus isolates in an in vitro pharmacodynamic model with simulated endocardial vegetations.
Cha R; Rybak MJ
Diagn Microbiol Infect Dis; 2003 Nov; 47(3):539-46. PubMed ID: 14596973
[TBL] [Abstract][Full Text] [Related]
17. Mechanistic Insights Into the Differential Efficacy of Daptomycin Plus β-Lactam Combinations Against Daptomycin-Resistant Enterococcus faecium.
Kebriaei R; Stamper KC; Singh KV; Khan A; Rice SA; Dinh AQ; Tran TT; Murray BE; Arias CA; Rybak MJ
J Infect Dis; 2020 Oct; 222(9):1531-1539. PubMed ID: 32514561
[TBL] [Abstract][Full Text] [Related]
18. Natural lipopeptide antibiotic tripropeptin C revitalizes and synergistically potentiates the activity of beta-lactams against methicillin-resistant Staphylococcus aureus.
Hashizume H; Takahashi Y; Harada S; Nomoto A
J Antibiot (Tokyo); 2015 Jun; 68(6):373-8. PubMed ID: 25586024
[TBL] [Abstract][Full Text] [Related]
19. Analysis of synergy between beta-lactams and anti-methicillin-resistant Staphylococcus aureus agents from the standpoint of strain characteristics and binding action.
Ono D; Yamaguchi T; Hamada M; Sonoda S; Sato A; Aoki K; Kajiwara C; Kimura S; Fujisaki M; Tojo H; Sasaki M; Murakami H; Kato K; Ishii Y; Tateda K
J Infect Chemother; 2019 Apr; 25(4):273-280. PubMed ID: 30713034
[TBL] [Abstract][Full Text] [Related]
20. Case report of a successful treatment of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia and MRSA/vancomycin-resistant Enterococcus faecium cholecystitis by daptomycin.
Tascini C; Di Paolo A; Polillo M; Ferrari M; Lambelet P; Danesi R; Menichetti F
Antimicrob Agents Chemother; 2011 May; 55(5):2458-9. PubMed ID: 21343441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
